Tags

Type your tag names separated by a space and hit enter

Novel approach of medialization thyroplasty with arytenoid adduction performed under general anesthesia with a laryngeal mask.
Otolaryngol Head Neck Surg. 2012 Feb; 146(2):266-71.OH

Abstract

OBJECTIVE

To objectively assess the voice outcomes of patients with unilateral vocal fold paralysis treated with medialization thyroplasty and arytenoid adduction suture.

STUDY DESIGN

Case series of patients who underwent medialization thyroplasty and arytenoid adduction suture. Preoperative and postoperative voice testing was performed and the data were compared by statistical analysis.

SETTING

Tertiary referral teaching hospital in Sydney, Australia.

SUBJECTS

All patients had a unilateral vocal fold paralysis, with a large posterior glottic gap and vocal symptoms affecting their quality of life.

METHODS

Thirteen patients with a diagnosis of a unilateral vocal fold paralysis with a large posterior glottic gap, vocal symptoms, and total denervation of the vocal fold underwent medialization thyroplasty and arytenoid adduction suture. The surgery was performed in a novel method under a general anesthetic using a laryngeal mask and with direct intraoperative endoscopic feedback. Preoperative and postoperative measures of voice performance were compared, including acoustic analysis (fundamental frequency, speech intensity against quiet and loud background noise, speech rate) and aerodynamic assessment (airflow, maximum phonation time).

RESULTS

Medialization thyroplasty with arytenoid adduction suture significantly improved aerodynamic assessment and phonation duration for both male and female subjects overall. There were 2 of 13 treatment failures. Median follow-up time was 6 months.

CONCLUSION

Preliminary results indicate that in selected patients with vocal fold paralysis, medialization thyroplasty with arytenoid adduction suture leads to significant improvements in objective voice measures. Longer follow-up data are required to further quantify the voice outcomes after this procedure.

Authors+Show Affiliations

Department of Otolaryngology, Mona Vale Hospital, NSW Australia.No affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

22075075

Citation

Stow, Nicholas W., et al. "Novel Approach of Medialization Thyroplasty With Arytenoid Adduction Performed Under General Anesthesia With a Laryngeal Mask." Otolaryngology--head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery, vol. 146, no. 2, 2012, pp. 266-71.
Stow NW, Lee JW, Cole IE. Novel approach of medialization thyroplasty with arytenoid adduction performed under general anesthesia with a laryngeal mask. Otolaryngol Head Neck Surg. 2012;146(2):266-71.
Stow, N. W., Lee, J. W., & Cole, I. E. (2012). Novel approach of medialization thyroplasty with arytenoid adduction performed under general anesthesia with a laryngeal mask. Otolaryngology--head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery, 146(2), 266-71. https://doi.org/10.1177/0194599811427811
Stow NW, Lee JW, Cole IE. Novel Approach of Medialization Thyroplasty With Arytenoid Adduction Performed Under General Anesthesia With a Laryngeal Mask. Otolaryngol Head Neck Surg. 2012;146(2):266-71. PubMed PMID: 22075075.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Novel approach of medialization thyroplasty with arytenoid adduction performed under general anesthesia with a laryngeal mask. AU - Stow,Nicholas W, AU - Lee,Jennifer W, AU - Cole,Ian E, Y1 - 2011/11/10/ PY - 2011/11/15/entrez PY - 2011/11/15/pubmed PY - 2014/3/19/medline KW - arytenoid adduction KW - medialization thyroplasty KW - vocal cord paralysis SP - 266 EP - 71 JF - Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery JO - Otolaryngol Head Neck Surg VL - 146 IS - 2 N2 - OBJECTIVE: To objectively assess the voice outcomes of patients with unilateral vocal fold paralysis treated with medialization thyroplasty and arytenoid adduction suture. STUDY DESIGN: Case series of patients who underwent medialization thyroplasty and arytenoid adduction suture. Preoperative and postoperative voice testing was performed and the data were compared by statistical analysis. SETTING: Tertiary referral teaching hospital in Sydney, Australia. SUBJECTS: All patients had a unilateral vocal fold paralysis, with a large posterior glottic gap and vocal symptoms affecting their quality of life. METHODS: Thirteen patients with a diagnosis of a unilateral vocal fold paralysis with a large posterior glottic gap, vocal symptoms, and total denervation of the vocal fold underwent medialization thyroplasty and arytenoid adduction suture. The surgery was performed in a novel method under a general anesthetic using a laryngeal mask and with direct intraoperative endoscopic feedback. Preoperative and postoperative measures of voice performance were compared, including acoustic analysis (fundamental frequency, speech intensity against quiet and loud background noise, speech rate) and aerodynamic assessment (airflow, maximum phonation time). RESULTS: Medialization thyroplasty with arytenoid adduction suture significantly improved aerodynamic assessment and phonation duration for both male and female subjects overall. There were 2 of 13 treatment failures. Median follow-up time was 6 months. CONCLUSION: Preliminary results indicate that in selected patients with vocal fold paralysis, medialization thyroplasty with arytenoid adduction suture leads to significant improvements in objective voice measures. Longer follow-up data are required to further quantify the voice outcomes after this procedure. SN - 1097-6817 UR - https://www.unboundmedicine.com/medline/citation/22075075/Novel_approach_of_medialization_thyroplasty_with_arytenoid_adduction_performed_under_general_anesthesia_with_a_laryngeal_mask_ L2 - https://journals.sagepub.com/doi/10.1177/0194599811427811?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub=pubmed DB - PRIME DP - Unbound Medicine ER -